BMEYE logo — Pioneering non-invasive cardiovascular monitoring with advan...

BMEYE

Pioneering non-invasive cardiovascular monitoring with advanced finger arterial pressure and cardiac output technologies for global healthcare.

Founded 2005 Series B Total: $6.00M Biotechnology, Health Care +1

General Information

Company Name BMEYE
Founded Year 2005
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series B
Social

Get notified when BMEYE moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BMEYE

**BMEYE** is a Netherlands-based non-invasive cardiovascular monitoring company that has been pioneering advanced finger arterial pressure and cardiac output technologies for global healthcare since **2005**. The company's product offerings include **Finapres**, **Portapres**, **Finometer**, **BeatScope**, **Modelflow**, **Space instrumentation**, **Cardiopres**, **Oxyflow**, **Nexfin**, and **ccNexfin**, catering to various fields such as cardiology, anesthesiology, sleep observation, physiology, neurology, and internal medicine; and emergency, acute, intensive, and intermediate care. Additionally, it has received a notable **€6.00M Series B investment** from **360 Capital, Earlybird, LSP BioVentures, TechFund** on **08 October 2009**. With a focus on the research and development of medical technologies for cardiovascular monitoring, BMEYE has positioned itself as a promising player in the **Biotechnology, Health Care, and Medical Devices** industries. The company's headquarters is located in **Amsterdam, the Netherlands**. BMEYE's dedication to innovation in non-invasive monitoring technologies, backed by significant investment, positions it as a noteworthy venture in the healthcare sector.

Taxonomy: cardiovascular monitoring, non-invasive monitoring, finger arterial pressure, cardiac output technologies, biomedical engineering, innovative medical devices, hemodynamics monitoring, cardiology technology, anesthesiology equipment, physiological measurement, global healthcare solutions

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 4
Investor Investor
•••• ••••
08 Oct 2009
Series A •••••• 3
Investor
•••• ••••
01 Jan 2009
Series A •••••• 3
Investor Investor
•••• ••••
21 Sep 2006

BMEYE Alternatives & Competitors

BMEYE vs

The leading technology for continuous non-invasive blood pressure measurement, autonomic testing and...

15 employees
Health Care, Medical Devices
BMEYE vs
RTM Vital SIgns
RTM Vital SIgns United States

Patented Solutions for Continuous, Real-time, and Accurate Vital Sign Monitoring of Ambulatory Patie...

Seed
5 employees
Biotechnology, Health Care
BMEYE vs
SunTech
SunTech United States

Clinical-Grade Non-Invasive Blood Pressure Technology and Medical Devices

107 employees
Health Care, Manufacturing

FAQ About BMEYE

Pioneering non-invasive cardiovascular monitoring with advanced finger arterial pressure and cardiac output technologies for global healthcare.
BMEYE was founded in 2005.
BMEYE operates in the following industries: Biotechnology, Health Care, Medical Devices.
BMEYE has completed 3 funding rounds, raising a total of $6.00M. The latest funding stage is Series B.
Top alternatives and competitors to BMEYE include Finapres Medical Systems, RTM Vital SIgns, SunTech, CNSystems Medizintechnik GmbH, Uscom. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BMEYE and Finapres Medical Systems are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BMEYE and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy